Search
for
Sort by
Research 931–960 of 1000+
- Human pollution exposure correlates with accelerated ultrastructural degradation of hair fibers
- Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre
- Modern hair restoration surgery
- Selective inhibition by minoxidil of prostacyclin production by cells in culture
- Injectable “Skin Boosters” in Aging Skin Rejuvenation: A Current Overview
- Symmetry breaking of tissue mechanics in wound induced hair follicle regeneration of laboratory and spiny mice
- A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women
- Graphene Oxide–IPDI–Ag/ZnO@Hydroxypropyl Cellulose Nanocomposite Films for Biological Wound-Dressing Applications
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Pediatric Psychocutaneous Disorders
- The Essence of Alternative Medicine
- Percutaneous Absorption of α-Tocopheryl Acetate
- Fabrication of polyvinyl pyrrolidone-K90/Eudragit RL100-based dissolving microneedle patches loaded with alpha-arbutin and resveratrol for skin depigmentation
- Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose
- A guide to studying human dermal adipocytes in situ
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- CCN2 modulates hair follicle cycling in mice
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- The stumptailed macaque as a model for androgenetic alopecia: Effects of topical minoxidil analyzed by use of the folliculogram
- Effect of the degree of acetylation on the physicochemical properties of α-chitin nanofibers
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- An Update on Drug-Induced Pigmentation
- Psychosomatic aspects of alopecia areata
- Androgenetic alopecia; drug safety and therapeutic strategies
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Secondary cicatricial and other permanent alopecias
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Novel inhibitors of 5α-reductase
- ADVANCES IN PSORIASIS THERAPY